Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | WT1 vaccine |
Trade Name | |
Synonyms | |
Drug Descriptions |
Multiple vaccines consisting of a variety of synthetic peptides derived from the human Wilms' Tumor (WT1) Protein used to induce a cytotoxic T-cell lymphocyte response against cells expressing WT1 (PMID: 25699052). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Montanide ISA 51 + Sargramostim + WT1 vaccine | Montanide ISA 51 Sargramostim WT1 vaccine | 0 | 1 |
Nivolumab + WT1 vaccine | Nivolumab WT1 vaccine | 0 | 1 |
WT1 vaccine | WT1 vaccine | 0 | 2 |